Effect of overweight on gastrointestinal microbiology and immunology: Correlation with blood biomarkers

British Journal of Nutrition

Volumn 103, Issue 7, 2010, Pages 1070-1078

  Tiihonen, Kirsti ^a   Ouwehand, Arthur C ^a   Rautonen, Nina ^a  

^a Danisco Finland Oy   (Finland)

Author keywords

Inflammation; Intestinal microbiota; Overweight

Indexed keywords

ADIPONECTIN; BIOGENIC AMINE; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CALGRANULIN; CHOLESTEROL; FATTY ACID DERIVATIVE; GHRELIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN; HORMONE; HYDROXYACID; IMMUNOGLOBULIN A; INSULIN; INTERLEUKIN 6; LEPTIN; LIPID; OREXIN; PEPTIDE YY; PHENOL; PROSTAGLANDIN E2; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; VALERIC ACID; AUTACOID; FATTY ACID; PHENOL DERIVATIVE;

ADULT; ARTICLE; BACTEROIDES; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FECES MICROFLORA; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; IMMUNOLOGY; INFLAMMATORY DISEASE; INSULIN BLOOD LEVEL; INTESTINE FLORA; LIPID BLOOD LEVEL; MALE; OBESITY; SATIETY; SULFATE REDUCING BACTERIUM; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; BACTERIUM; BLOOD; CHEMISTRY; CLASSIFICATION; COMPARATIVE STUDY; FECES; INTESTINE; METABOLISM; MICROBIOLOGY; MIDDLE AGED; REFERENCE VALUE;

BACTEROIDES;

ADULT; BACTERIA; BIOLOGICAL MARKERS; BLOOD GLUCOSE; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; FATTY ACIDS; FECES; FEMALE; HORMONES; HUMANS; HYDROXY ACIDS; INFLAMMATION MEDIATORS; INSULIN; INTERLEUKIN-6; INTESTINES; LIPIDS; MALE; MIDDLE AGED; OBESITY; PHENOLS; REFERENCE VALUES; WAIST CIRCUMFERENCE;

EID: 77951230727     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114509992807     Document Type: Article

References (57)

1. Peeters A, Barendregt JJ, Willekens F, et al. (2003) Obesity in adulthood and its consequences for life expectancy: a life-table analysis. Ann Intern Med 138, 24-32.
2. Mikkola I, Keinanen-Kiukaanniemi S, Laakso M, et al. (2007) Metabolic syndrome in connection with BMI in young Finnish male adults. Diabetes Res Clin Pract 76, 404-409.
3. Esteghamati A, Khalilzadeh O, Anvari M, et al. (2008) Metabolic syndrome and insulin resistance significantly correlate with body mass index. Arch Med Res 39, 803-808.
4. Yudkin JS, Stehouwer CDA, Emeis JJ, et al. (1999) C-reactive protein in wealthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction-a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 19, 972-978.
5. Dandona P, Aljada A & Bandyopadhyay A (2004) Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol 25, 4-7.
6. Bahceci M, Gokalp D, Bahceci S, et al. (2007) The correlation between adiposity and adiponectin tumor necrosis factor alpha, interleukin-6 and high sensitivity C-reactive protein levels. Is adipocyte size asssociated with inflammation in adults? J Endo-crinol Invest 30, 210-214.
7. Festa A, D'Agostino R, Williams K, et al. (2001) The relation of body fat mass and distribution to markers of chronic inflammation. Int J Obes 25, 1407-1415.
8. Diamond JM & Karasov WH (1987) Adaptive regulation of intestinal nutrient transporters. Proc Natl Acad Sci USA 84, 2242-2245.
9. Diamond J (1991) Evolutionary design of nutrient absorption: enough but not too much. News Physiol Sci 6, 92-96.
10. Ley RE, Turnbaugh PJ, Klein S, et al. (2006) Microbial ecology-human gut microbes associated with obesity. Nature 444, 1022-1023.
11. Turnbaugh PJ, Ley RE, Mahowald MA, et al. (2006) An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444, 1027-1031.
12. Lyly M, Soini E, Rauramo U, et al. (2004) Perceived role of fibre in a healthy diet among Finnish consumers. J Hum Nutr Diet 17, 231-239.
13. Cristie WW (1989) Gas Chromatography and Lipids, A Practical Guide. Glasgow: The Oily Press Ltd.
14. Knust U, Erben G, Spiegelhalder B, et al. (2006) Identification and quantitation of phenolic compounds in faecal matrix by capillary gas chromatography and nano-electrospray mass spectrometry. Rapid Commun Mass Spectrom 20, 3119-3129.
15. Miller RS & Hoskins LC (1981) Mucin degradation in human colon ecosystems. Fecal population densities of mucin- degradingbacteriaestimatedbya'mostprobable number' method. Gastroenterology 81, 759-765.
16. Ouwehand AC, Tiihonen K, Saarinen M, et al. (2009) Influence of a combination of Lactobacillus acidophilus NCFM and lactitol on healthy elderly: intestinal and immune parameters. Br J Nutr 101, 367-375.
17. Saarinen M (2002) Determination of biogenic amines as dansyl derivatives in intestinal digesta and feces by reversed phase HPLC. Chromatographia 55, 297-300.
18. Apajalahti JH, Kettunen H, Kettunen A, et al. (2002) Culture-independent microbial community analysis reveals that inulin in the diet primarily affects previously unknown bacteria in the mouse cecum. Appl Environ Microbiol 68, 4986-4995.
19. Apajalahti JH, Sarkilahti LK, Maki BR, et al. (1998) Effective recovery of bacterial DNA and percent-guanine-plus-cytosine-based analysis of community structure in the gastrointestinal tract of broiler chickens. Appl Environ Microbiol 64, 4084-4088.
20. Couillard C, Bergeron N, Prud'homme D, et al. (1998) Postprandial triglyceride response in visceral obesity in men. Diabetes 47, 953-960.
21. Considine RV (1997) Leptin and obesity in humans. Eat Weight Disord 2, 61-66.
22. Tschop M, Weyer C, Tataranni PA, et al. (2001) Circulating ghre-lin levels are decreased in human obesity. Diabetes 50, 707-709.
23. Compher C & Badellino KO (2008) Obesity and inflammation: lessons from bariatric surgery. JPEN J Parenter Enteral Nutr 32, 645-647.
24. Trayhurn P, Wang B & Wood IS (2008) Hypoxia and the endocrine and signalling role of white adipose tissue. Arch Physiol Biochem 114, 267-276.
25. Cartier A, Lemieux I, Almeras N, et al. (2008) Visceral obesity and plasma glucose-insulin homeostasis: contributions of interleukin-6 and tumor necrosis factor-alpha in men. J Clin Endocrinol Metab 93, 1931-1938.
26. McGillicuddy FC, de la Llera MM, Hinkle CC, et al. (2009) Inflammation impairs reverse cholesterol transport in vivo. Circulation 119, 1135-1145.
27. Cani PD, AmarJ,Iglesias MA, etal. (2007) Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56, 1761-1772.
28. Cani PD, Bibiloni R, Knauf C, et al. (2008) Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57, 1470-1481.
29. Weyer C, Funahashi T, Tanaka S, et al. (2001) Hypoadiponec-tinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86, 1930-1935.
30. Tiihonen K, Tynkkynen S, Ouwehand A, et al. (2008) The effect of ageing with and without non-steroidal anti-inflammatory drugs on gastrointestinal microbiology and immunology. Br J Nutr 100, 130-137.
31. Ouwehand AC, Nermes M, Collado MC, et al. (2009) Specific probiotics alleviate allergic rhinitis during the birch pollen season. World J Gastroenterol 15, 3261-3268.
32. Foell D, Wittkowski H & Roth J (2009) Monitoring disease activity by stool analyses: from occult blood to molecular markers of intestinal inflammation and damage. Gut 58, 859-868.
33. Tsianos EV & Katsanos K (2009) Do we really understand what the immunological disturbances in inflammatory bowel disease mean? World J Gastroenterol 15, 521-525.
34. Yadav PK & Liu Z (2009) Current strategies for the treatment of ulcerative colitis. Recent Pat Inflamm Allergy Drug Discov 3, 65-72.
35. Cummings JH & Macfarlane GT (1991) The control and consequences of bacterial fermentation in the human colon. J Appl Bacteriol 70, 443-459.
36. Makivuokko H, Tiihonen K, Tynkkynen S, et al. (2009) The effect of age and non-steroidal anti-inflammatory drugs on human intestinal microbiota composition. Br J Nutr (Epublica-tion ahead of print version 25 August 2009).
37. Kalliomaki M, Collado MC, Salminen S, et al. (2008) Early differences in fecal microbiota composition in children may predict overweight. Am J Clin Nutr 87, 534-538.
38. Malinen E, Rinttila T, Kajander K, et al. (2005) Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR. Am J Gastroenterol 100, 373-382.
39. Schwiertz A, Taras D, Schafer K, et al. (2009) Microbiota and SCFA in lean and overweight healthy subjects. Obesity (Silver Spring) (Epublication ahead of print version 4 June 2009).
40. Samuel BS, Shaito A, Motoike T, et al. (2008) Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41. Proc Natl Acad Sci USA 105, 16767-16772.
41. Bray GA (2000) Afferent signals regulating food intake. Proc Nutr Soc 59, 373-384.
42. Hughes R & Rowland IR (2000) Metabolic activities of the gut microflora in relation to cancer. Microb Ecol Health Dis 11, 179-185.
43. Rafter JJ (2002) Scientific basis of biomarkers and benefits of functional foods for the reduction of disease risk: cancer. Br J Nutr 88, S219-S224.
44. Scheppach W & Weiler F (2004) The butyrate story: old wine in new bottles. Curr Opin Clin Nutr Metab Care 7, 563-567.
45. Larsson SC & Wolk A (2007) Obesity and colon and rectal cancer risk: a meta-analysis of prospective studies. Am J Clin Nutr 86, 556-565. (Pubitemid 47435820)
46. Duncan SH, Louis P & Flint HJ (2004) Lactate-utilizing bacteria, isolated from human feces, that produce butyrate as a major fermentation product. Appl Environ Microbiol 70, 5810-5817.
47. Ritzhaupt A, Wood IS, Ellis A, et al. (1998) Identification and characterization of a monocarboxylate transporter (MCT1) in pig and human colon: its potential to transport L-lactate as well as butyrate. J Physiol (Pt 3), 513, 719-732.
48. Lombardi AM, Fabris R, Bassetto F, et al. (1999) Hyperlactate-mia reduces muscle glucose uptake and GLUT-4 mRNA while increasing (E1alpha)PDH gene expression in rat. Am J Physiol 276, E922-E929.
49. DiGirolamo M, Newby FD & Lovejoy J (1992) Lactate production in adipose tissue: a regulated function with extra-adipose implications. FASEB J 6, 2405-2412.
50. Chan L, Slater J, Hasbargen J, et al. (1994) Neurocardiac toxicity of racemic D,L-lactate fluids. Integr Physiol Behav Sci 29, 383-394.
51. Vella A & Farrugia G (1998) D-Lactic acidosis: pathologic consequence of saprophytism. Mayo Clin Proc 73, 451-456.
52. Jenner AM, Rafter J & Halliwell B (2005) Human fecal water content of phenolics: the extent of colonic exposure to aromatic compounds. Free Radic Biol Med 38, 763-772.
53. Reigstad CS, Lunden GO, Felin J, et al. (2009) Regulation of serum amyloid A3 (SAA3) in mouse colonic epithelium and adipose tissue by the intestinal microbiota. PLoS One 4, e5842.
54. Makivuokko H, Nurmi J, Nurminen P, et al. (2005) In vitro effects on polydextrose by colonic bacteria and caco-2 cell cyclooxygenase gene expression. Nutr Cancer 52, 94-104.
55. Byun R, Nadkarni MA, Chhour KL, et al. (2004) Quantitative analysis of diverse Lactobacillus species present in advanced dental caries. J Clin Microbiol 42, 3128-3136.
56. Song Y, Liu C & Finegold SM (2004) Real-time PCR quanti-tation of clostridia in feces of autistic children. Appl Environ Microbiol 70, 6459-6465.
57. Nakanishi Y, Murashima K, Ohara H, et al. (2006) Increase in terminal restriction fragments of Bacteroidetes-derived 16S rRNA genes after administration of short-chain fructooligosac-charides. Appl Environ Microbiol 72, 6271-6276.